Trials / Unknown
UnknownNCT04518163
Bakri Balloon Plus Tranexamic Acid During Cesarean Delivery for Placenta Previa
Bakri Balloon Tamponade Plus Intravenous Tranexamic Acid During Cesarean Delivery for Placenta Previa: a Randomized Double-blind Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Objective to investigate the effect of adjunctive intravenous tranexamic acid (TA) on blood loss during cesarean section (CS) in patients with placenta previa undergone Bakri balloon tamponade
Detailed description
Placenta previa (PP) is an obstetric condition that is closely linked with massive obstetric hemorrhage with a varied incidence about once in every 200 live births. It is considered one of the causes of the increased need for blood transfusion and cesarean hysterectomy. PPH due to PP typically starts during cesarean section (CS) in the placental bed, at the lower uterine segment mostly after placental separation. Proceeding for cesarean hysterectomy can be the only effective line of management in spite of the associated high morbidity rate. Tranexamic acid is a lysine analog which acts as an antifibrinolytic via competitive inhibition of the binding of plasmin and plasminogen to fibrin. The rationale for its use in the reduction of blood loss depending on the implication of the coagulation and fibrinolysis processes implicated in the control of PPH. However, concerns about possible thromboembolic events with parenteral administration of TA have stimulated increasing interest in its topical use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid | Intravenous 1 gm tranexamic acid in 100 ml saline by slow infusion before skin incision |
| DRUG | placebo to TA | Intravenous 110 ml saline by slow infusion before skin incision |
| DEVICE | Bakri Balloon | Bakri balloon was inserted into the lower uterine segment through the uterine incision by passing the balloon shaft through the cervix with an assistant pulling vaginally |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2022-06-30
- Completion
- 2022-07-31
- First posted
- 2020-08-19
- Last updated
- 2020-09-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04518163. Inclusion in this directory is not an endorsement.